US2022340544A1PendingUtilityA1

Substituted heterocyclic derivatives as pi3k inhibitors

Assignee: INCYTE CORPPriority: Nov 13, 2018Filed: Jun 22, 2022Published: Oct 27, 2022
Est. expiryNov 13, 2038(~12.3 yrs left)· nominal 20-yr term from priority
C07D 401/14C07D 491/107C07D 403/14C07D 405/14A61P 25/28A61P 9/00A61P 35/00A61P 25/00A61P 37/00
69
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

This application relates to compounds of Formula (I):or pharmaceutically acceptable salts thereof, which are inhibitors of PI3K-γ which are useful for the treatment of disorders such as autoimmune diseases, cancer, cardiovascular diseases, and neurodegenerative diseases.

Claims

exact text as granted — not AI-modified
1 - 35 . (canceled) 
     
     
         36 . A method of inhibiting an activity of PI3Kγ kinase, comprising contacting the kinase with a compound of Formula (IIu): 
       
         
           
           
               
               
           
         
         or a pharmaceutically acceptable salt thereof, wherein:
 Z is CZ 1  or N; 
 Z 1  and R 12  are each independently selected from H, D, OH, NO 2 , CN, halo, C 1-3  alkyl, C 2-3  alkenyl, C 2-3  alkynyl, C 1-3  haloalkyl, cyano-C 1-3  alkyl, HO-C 1-3  alkyl, C 1-3  alkoxy-C 1-3  alkyl, C 3-6  cycloalkyl, C 1-3  alkoxy, C 1-3  haloalkoxy, amino, C 1-3  alkylamino, di(C 1-3  alkyl)amino, thio, C 1-3  alkylthio, C 1-3  alkylsulfinyl, C 1-3  alkylsulfonyl, carbamyl, C 1-3  alkylcarbamyl, di(C 1-3  alkyl)carbamyl, carboxy, C 1-3  alkylcarbonyl, C 1-4  alkoxycarbonyl, C 1-3  alkylcarbonylamino, C 1-3  alkoxycarbonylamino, C 1-3  alkylcarbonyloxy, aminocarbonyloxy, C 1-3  alkylaminocarbonyloxy, di(C 1-3  alkyl)aminocarbonyloxy, C 1-3  alkylsulfonylamino, aminosulfonyl, C 1-3  alkylaminosulfonyl, alkyl)aminosulfonyl, aminosulfonylamino, C 1-3  alkylaminosulfonylamino, di (C 1-3  alkyl)aminosulfonylamino, aminocarbonylamino, C 1-3  alkylaminocarbonylamino, and di(C 1-3  alkyl)aminocarbonylamino; 
 
         R 1  is selected from H, D, halo, C 1-6  alkyl, C 1-6  haloalkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, (4-10 membered heterocycloalkyl)-C 1-6  alkyl-, CN, NO 2 , —OR a1 , —SR a1 , —C(O)R b1 , —C(O)NR c1 R d1 , —C(O)NR c1 (OR a1 ), —C(O)OR a1 , —OC(O)R b1 , —OC(O)NR c1 R d1 , —NR c1 R d1 , —NR c1 NR c1 R d1 , —NR c1 C(O)R b1 , —NR c1 C(O)OR a1 , and —NR c1 C(O)NR c1 R d1 , wherein the C 1-6  alkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, and (4-10 membered heterocycloalkyl)-C 1-6  alkyl- of R 1  are each optionally substituted with 1, 2, 3, 4, 5, 6, 7, or 8 independently selected R 1A  substituents; 
         each R a1 , R b1 , R c1 , and R d1  is independently selected from H, C 1-6  alkyl, C 1-6  haloalkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, and (4-10 membered heterocycloalkyl)-C 1-6  alkyl-, wherein the C 1-6  alkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, and (4-10 membered heterocycloalkyl)-C 1-6  alkyl- of R a1 , R b1 , R c1  and R d1  are each optionally substituted with 1, 2, 3, 4, 5, 6, 7, or 8 independently selected R 1A  substituents; 
         or, any R c1  and R d1 , attached to the same N atom, together with the N atom to which they are attached, form a 5-10 membered heteroaryl group or a 4-10 membered heterocycloalkyl group, wherein the 5-10 membered heteroaryl group or 4-10 membered heterocycloalkyl group is optionally substituted with 1, 2, 3, 4, 5, 6, 7, or 8 independently selected R 1A  substituents; 
         each R 1A  is selected from H, D, halo, C 1-6  alkyl, C 1-6  haloalkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, (4-10 membered heterocycloalkyl)-C 1-6  alkyl-, CN, NO 2 , —OR a11 , —SR a11 , —NHOR a11 , —C(O)R b11 , —C(O)NR c11 R d11 , —C(O)NR c11 (OR a11 ), —C(O)OR a11 , —OC(O)R b11 , —OC(O)NR c11 R d11 , —NR c11 R d11 , —NR c11 R c11 R d11 , —NR c11 C(O)R b11 , —NR a11 , and —NR c11 C(O)NR c11 R 11 , wherein the C 1-6  alkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, and (4-10 membered heterocycloalkyl)-C 1-6  alkyl- of R 1A  are each optionally substituted with 1, 2, 3, 4, 5, 6, 7, or 8 independently selected R M  substituents; 
         each R a11 , R b11 , R a11 , and R d11  is independently selected from H, C 1-6  alkyl, C 1-6  haloalkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, and (4-10 membered heterocycloalkyl)-C 1-6  alkyl-, wherein the C 1-6  alkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, and (4-10 membered heterocycloalkyl)-C 1-6  alkyl- of R a11 , R b11 , R a11 and R d11  are each optionally substituted with 1, 2, 3, 4, 5, 6, 7, or 8 independently selected R M  substituents; 
         or, any R c11  and R d11 , attached to the same N atom, together with the N atom to which they are attached, form a 5-10 membered heteroaryl group or a 4-10 membered heterocycloalkyl group, wherein the 5-10 membered heteroaryl group or 4-10 membered heterocycloalkyl group is optionally substituted with 1, 2, 3, 4, 5, 6, 7, or 8 independently selected R M  substituents; 
         each R M  is independently selected from D, OH, NO 2 , CN, halo, alkyl, C 2-3  alkenyl, C 2-3  alkynyl, C 1-3  haloalkyl, cyano-C 1-3  alkyl, HO—C 1-3  alkyl, alkoxy-C 1-3  alkyl, C 3-6  cycloalkyl, alkoxy, C 1-3  haloalkoxy, amino, alkylamino, di(C 1-3  alkyl)amino, thio, C 1-3  alkylthio, alkylsulfinyl, C 1-3  alkylsulfonyl, carbamyl, C 1-3  alkylcarbamyl, di(C 1-3  alkyl)carbamyl, carboxy, C 1-3  alkylcarbonyl, C 1-4  alkoxycarbonyl, C 1-3  alkylcarbonylamino, C 1-3  alkoxycarbonylamino, C 1-3  alkylcarbonyloxy, aminocarbonyloxy, C 1-3  alkylaminocarbonyloxy, di(C 1-3  alkyl)aminocarbonyloxy, C 1-3  alkylsulfonylamino, aminosulfonyl, C 1-3  alkylaminosulfonyl, alkyl)aminosulfonyl, aminosulfonylamino, C 1-3  alkylaminosulfonylamino, alkyl)aminosulfonylamino, aminocarbonylamino, C 1-3  alkylaminocarbonylamino, and di(C 1-3  alkyl)aminocarbonylamino; 
         R 2  is selected from H, D, halo, C 1-6  alkyl, C 1-6  haloalkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, (4-10 membered heterocycloalkyl)-C 1-6  alkyl-, CN, NO 2 , —OR a2 , —SR a2 , —NHOR a2 , —C(O)R b2 , —C(O)NR C2 R d2 , —C(O)NR c2 (OR a2 ), C(O)OR a2 , —OC(O)R b2 , —OC(O)NR c2 R d2 , —NR c2 R d2 , —NR c2 NR c2 R d2 , —NR c2 C(O)R b2 , —NR c2 C(O)OR a2 , and —NR c2 C(O)NR c2 R d2 , wherein the C 1-6  alkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, and (4-10 membered heterocycloalkyl)-C 1-6  alkyl- of R 2  are each optionally substituted with 1, 2, 3, 4, 5, 6, 7, or 8 independently selected R 2A  substituents; 
         each R a2 , R b2 , R c2 , R d2  is independently selected from H, C 1-6  alkyl, C 1-6  haloalkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, and (4-10 membered heterocycloalkyl)-C h6  alkyl-, wherein the C 1-6  alkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, and (4-10 membered heterocycloalkyl)-C 1-6  alkyl- of R a2 , R b2 , R c2    and R   d2  are each optionally substituted with 1, 2, 3, 4, 5, 6, 7, or 8 independently selected R 2A  substituents; 
         or, any R c2  and R d2 , attached to the same N atom, together with the N atom to which they are attached, form a 5-10 membered heteroaryl group or a 4-10 membered heterocycloalkyl group, wherein the 5-10 membered heteroaryl group or 4-10 membered heterocycloalkyl group is optionally substituted with 1, 2, 3, 4, 5, 6, 7, or 8 independently selected R 2A  substituents; 
         each R 2A  is selected from H, D, halo, C 1-6  alkyl, C 1-6  haloalkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, (4-10 membered heterocycloalkyl)-C 1-6  alkyl-, CN, NO 2 , —OR a21 , —SR a21 , —NHOR a21 , —C(O)R b21 , —C(O)NR c21 R d21 , —C(O)NR c21 (OR a21 ), —C(O)OR a21 , —OC(O)R b21 , —OC(O)NR c21 R d21 , —NR c21 R d21 , NR c21 NR c21 R d21 , —NR c21 C(O)R b21 , —NR c21  C(O)OR a21 , and —NR c21 C(O)NR c21 R d21 , alkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, and (4-10 membered heterocycloalkyl)-C 1-6  alkyl- of R 2A  are each optionally substituted with 1, 2, 3, 4, 5, 6, 7, or 8 independently selected R M  substituents; 
         each R a21 , R b21 , R c21 , and R d21  is independently selected from H, C 1-6  alkyl, C 1-6  haloalkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, and (4-10 membered heterocycloalkyl)-C h6  alkyl-, wherein the C 1-6  alkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, and (4-10 membered heterocycloalkyl)-C 1-6  alkyl- of R a21 , R b21 , R c21  and R d21  are each optionally substituted with 1, 2, 3, 4, 5, 6, 7, or 8 independently selected R M  substituents; 
         or, any R c21  and R d21 , attached to the same N atom, together with the N atom to which they are attached, form a 5-10 membered heteroaryl group or a 4-10 membered heterocycloalkyl group, wherein the 5-10 membered heteroaryl group or 4-10 membered heterocycloalkyl group is optionally substituted with 1, 2, 3, 4, 5, 6, 7, or 8 independently selected R M  substituents; 
         or alternatively, R 1  and R 2 , taken together with the carbon atoms to which they are attached form a monocyclic 4-7 membered cycloalkyl ring, a phenyl ring, a monocyclic 4-7 membered heterocycloalkyl ring, or a monocyclic 5-6 membered heteroaryl ring, each of which is optionally substituted by 1, 2, 3, 4, 5, 6, 7 or 8 independently selected R 1A  groups; 
         R 6  is selected from H, D, halo, C 1-6  alkyl, C 1-6  haloalkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, (4-10 membered heterocycloalkyl)-C 1-6  alkyl-, CN, NO 2 , —OR a6 , —SR a6 , —NHOR a6 , —C(O)R b6 , —C(O)NR c6 R d6 , —C(O)NR c6 (OR a6 ), —C(O)OR a6 , —OC(O)R b6 , —OC(O)NR c6 R d6 NR C6 R d6 , —NR c6 NR c6 R d6 , —NR c6 C(O)R b6 , —NR c6 C(O)OR a6 , —NR c6 C(O)NR c6 R d6 , —C(═NR e6 )R b6 , —C(═NOH)R d6 , —C(═NCN)R b6 , —C(═NR e6 )NR c6 R d6 , —NR c6 C(═NR e6 )NR c6 R d6 , —NR c6 C(═NOH)NR c6 R d6 , —NR c6 C(═NCN)NR c6 R d6 , —NR c6 C(═NR e6 )R b6 , —NR c6 S(O)NR c6 R d6 , —NR c6 S(O)R b6 , —NR c6 S(O) 2 R b6 , —NR c6 S(O)(═NR e6 )R b6 , —NR c6 S(O) 2 NR c6 R d6 , —S(O)R b6 , —S(O)NR c6 R d6 , —S(O) 2 R b6 , —S(O) 2 NR c6 R d6 , —S(O)(═NR e6 )R b6 , —N═S(O)R a6 R b6 , —OS(O)(═NR e6 )R b6 , —OS(O) 2 R b6 , and —SF 5 , wherein the C 1-6  alkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, and (4-10 membered heterocycloalkyl)-C 6 alkyl- of R 6  are each optionally substituted with 1, 2, 3, 4, 5, 6, 7, or 8 independently selected R 6A  substituents; 
         each R a6 , and R b6 , R c6 , R d6 , and R e6  is independently selected from H, C 1-6  alkyl, C 1-6  haloalkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, and (4-10 membered heterocycloalkyl)-C 1-6  alkyl-, wherein the C 1-6  alkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, and (4-10 membered heterocycloalkyl)-C 1-6  alkyl- of R a6 , R b6 , R c6 , R d6 , and R e6  are each optionally substituted with 1, 2, 3, 4, 5, 6, 7, or 8 independently selected R 6A  substituents; 
         or, any R c6  and R d6 , attached to the same N atom, together with the N atom to which they are attached, form a 5-10 membered heteroaryl group or a 4-10 membered heterocycloalkyl group, wherein the 5-10 membered heteroaryl group or 4-10 membered heterocycloalkyl group is optionally substituted with 1, 2, 3, 4, 5, 6, 7, or 8 independently selected R 6A  substituents; 
         each R 6A  is selected from H, D, halo, C 1-6  alkyl, C 1-6  haloalkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, (4-10 membered heterocycloalkyl)-C 1-6  alkyl-, CN, NO 2 , —OR a61 , —SR a61 , —NHOR a61 , —C(O)R b61 , —C(O)NR c61 R d61 , —C(O)NR c61 (OR a61 ), —C(O)OR a61 , —OC(O)R b61 , —OC(O)NR c61 R d61 , —NR c61 R d61 , —NR c61 NR c61 R d61 , —NR c61 C(O)R b61 , —NR c61 C(O)OR a61 , and —NR c61 C(O)NR c61 R d61 , wherein the C 1-6  alkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, and (4-10 membered heterocycloalkyl)-C 1-6  alkyl- of R 6A  are each optionally substituted with 1, 2, 3, 4, 5, 6, 7, or 8 independently selected R M  substituents; 
         each R a61 , R b61 , R c61 , and R d61  is independently selected from H, C 1-6  alkyl, C 1-6  haloalkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, and (4-10 membered heterocycloalkyl)-C h6  alkyl-, wherein the C 1-6  alkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, and (4-10 membered heterocycloalkyl)-C 1-6  alkyl- of R a61 , R b61 , R c61  and R d61  are each optionally substituted with 1, 2, 3, 4, 5, 6, 7, or 8 independently selected R M  substituents; 
         or, any R c61  and R d61 , attached to the same N atom, together with the N atom to which they are attached, form a 5-10 membered heteroaryl group or a 4-10 membered heterocycloalkyl group, wherein the 5-10 membered heteroaryl group or 4-10 membered heterocycloalkyl group is optionally substituted with 1, 2, 3, 4, 5, 6, 7, or 8 independently selected R M  substituents; 
         X 9  is —NR 9N  or —C(R 9 ) 2 ; 
         X 11  is —NR 11N  or —C(R 11 ) 2: , 
         R 9N  is selected from H, C 1-6  alkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 1-6  haloalkyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, (4-10 membered heterocycloalkyl)-C 1-6  alkyl-, —C(O)R b9N , —C(O)NR c9N R d9N , —C(O)OR a9N . —C(═NR e9N )R b9N , C(═NR e9N )NR c9N R d9N , —C(═NCN)NR c9N R d9N , —C(═NOR a9N )NR c9N , —S(O) 2 R b9N , —S(O)(═NR c9N )R d9N , (and —S(O) 2 NR c9N -R d9N , wherein the C 1-6  alkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl- and (4-10 membered heterocycloalkyl)-C 1-6  alkyl- of R 9N  are each optionally substituted with 1, 2, 3, 4, 5, 6, 7, or 8 independently selected R 9NA  substituents; 
         each R a9N , R b9N , R c9N , and R d9N  is independently selected from H, C 1-6  alkyl, C 1-6  haloalkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, and (4-10 membered heterocycloalkyl)-C 1-6  alkyl-, wherein the C 1-6  alkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, and (4-10 membered heterocycloalkyl)-C 1-6  alkyl- of R a9N , R b9N , R c9N , and R d9N  are each optionally substituted with 1, 2, 3, 4, 5, 6, 7, or 8 independently selected R 9NA  substituents; 
         or, any R c9N  and R d9N , attached to the same N atom, together with the N atom to which they are attached, form a 5-10 membered heteroaryl group or a 4-10 membered heterocycloalkyl group, wherein the 5-10 membered heteroaryl group or 4-10 membered heterocycloalkyl group is optionally substituted with 1, 2, 3, 4, 5, 6, 7, or 8 independently selected R 9NA  substituents; 
         each R e9N  is independently selected from H, OH, CN, C 1-6  alkyl, C 1-6  alkoxy, C 1-6  haloalkyl, C 1-6  haloalkoxy, C 2-6  alkenyl, and C 2-6  alkynyl; 
         each R 9NA  is selected from H, D, halo, C 1-6  alkyl, C 1-6  haloalkyl, C 2-6  alkenyl, C 2-6  alkynyl, phenyl, C 3-7  cycloalkyl, 5-6 membered heteroaryl, 4-7 membered heterocycloalkyl, phenyl-C 1-6  alkyl-, C 3-7  cycloalkyl-C 1-6  alkyl-, (5-6 membered heteroaryl)-C 1-6  alkyl-, (4-7 membered heterocycloalkyl)-C 1-6  alkyl-, CN, NO 2 , —OR a9N2 , —SR a9N2 , —NHOR a9N2 , —C(O)R b9N2 , —C(O)NR c9N2 R d9N2 , —C(O)NR c9N2 (OR a9N2 ), —C(O)OR a9N2 , —OC(O)R b9N2 , —OC(O)NR c9N R d9N2 , NR c9N2 R d9N2 , —NR C9N2  NR C9N2  R d9N2 , —NR C9N2 C(O)R b9N2 , —NR C9N2  C(O)OR a9N2 , —NR c9N2 C(O) NR   c9N2 R d9N2 ; wherein the C 1-6  alkyl, C 2-6  alkenyl, C 2-6  alkynyl, phenyl, C 3-7  cycloalkyl, 5-6 membered heteroaryl, 4-7 membered heterocycloalkyl, phenyl-C 1-6  alkyl-, C 3-7  cycloalkyl-C 1-6  alkyl-, (5-6 membered heteroaryl)-C 1-6  alkyl-, and (4-7 membered heterocycloalkyl)-C 1, 6  alkyl- of R 9NA  are each optionally substituted with 1, 2, 3, or 4 independently selected R M  substituents; 
         each R a9N2 , R b9N2 , R c9N2 , and R d9N2  is independently selected from H, C 1-6  alkyl, C 1-6  haloalkyl, C2,6 alkenyl, C2,6 alkynyl, phenyl, C 3-7  cycloalkyl, 5-6 membered heteroaryl, 4-7 membered heterocycloalkyl, phenyl-C 1-6  alkyl-, C 3-7  cycloalkyl-C 1-6  alkyl-, (5-6 membered heteroaryl)-C 1-6  alkyl-, and (4-7 membered heterocycloalkyl)-C 1-6  alkyl-, wherein the C 1-6  alkyl, C 2-6  alkenyl, C2,6 alkynyl, phenyl, C 3-7  cycloalkyl, 5-6 membered heteroaryl, 4-7 membered heterocycloalkyl, phenyl-C 1-6  alkyl-, C 3-7  cycloalkyl-C 1-6  alkyl-, (5-6 membered heteroaryl)-C 1-6  alkyl-, and (4-7 membered heterocycloalkyl)-C 1-6  alkyl- of R a9N2 , R b9N2 , R c9N2  and R d9N2  are each optionally substituted with 1, 2, 3, or 4 independently selected R M  substituents; 
         or, any R c9N2  and R d9N2 , attached to the same N atom, together with the N atom to which they are attached, form a 5-6 membered heteroaryl group or a 4-7 membered heterocycloalkyl group, wherein the 5-6 membered heteroaryl group or 4-7 membered heterocycloalkyl group is optionally substituted with 1, 2, 3, or 4 independently selected R M  substituents; 
         each R 9  is independently selected from H, D, halo, C 1-6  alkyl, C 1-6  haloalkyl, C2,6 alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, (4-10 membered heterocycloalkyl)-C 1-6  alkyl-, CN, NO 2 , —OR a91 , -SR a91 , —NHOR a91 , —C(O)R b91 , —C(O)NR c91 R d91 , —C(O)NR c91 (OR a91 ), C(O)OR a91 , —OC(O)R b91 , —OC(O)NR c91 R d91 , —NR c91 R d91 , —NR c91 NR c91 R d91 , —NR c91 C(O)R b91 , —NR c91   C(O)OR   a91 , and —NR c91 C(O)NR c91 R d91 , wherein the C 1-6  alkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, and (4-10 membered heterocycloalkyl)-C 1-6  alkyl- of R9 are each optionally substituted with 1, 2, 3, 4, 5, 6, 7, or 8 independently selected R 9A  substituents; 
         or, alternatively, two R 9  groups together form an oxo group; 
         each R a91 , R b91 , R c91 , and R d91  is independently selected from H, C 1-6  alkyl, C 1-6  haloalkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, and (4-10 membered heterocycloalkyl)-C 1-6  alkyl-, wherein the C 1-6  alkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, and (4-10 membered heterocycloalkyl)-C 1-6  alkyl- of R a91 , R b91 , R c91  and R d91  are each optionally substituted with 1, 2, 3, 4, 5, 6, 7, or 8 independently selected R 9A  substituents; 
         or, any R c91  and R d91 , attached to the same N atom, together with the N atom to which they are attached, form a 5-10 membered heteroaryl group or a 4-10 membered heterocycloalkyl group, wherein the 5-10 membered heteroaryl group or 4-10 membered heterocycloalkyl group is optionally substituted with 1, 2, 3, 4, 5, 6, 7, or 8 independently selected R 9A  substituents; 
         each R 9A  is selected from H, D, halo, C 1-6  alkyl, C 1-6  haloalkyl, C 2-6  alkenyl, C 2-6  alkynyl, phenyl, C 3-7  cycloalkyl, 5-6 membered heteroa 1 4-7 membered heteroc cloalk 1 phenyl-C 1-6  alkyl-, C 3-7  cycloalkyl-C 1-6  alkyl-, (5-6 membered heteroaryl)-C 1-6  alkyl-, (4-7 membered heterocycloalkyl)-C 1-6  alkyl-, CN, NO 2 , —OR a92 , —SR a92 , —NHOR a92 , —C(O)R b92 , —C(O)NR c92 R d92 , —C(O)NR c92 (OR a92 ), —C(O)OR a92 , —OC(O)R b92 , —OC(O)NR c92 R d92 , —NR c92 R d92 , —NR c92 NR c92 R d92 , —NR c92 C(O)R b92 , —NR c92 C(O)OR a92 , and —NR c92 C(O)NR c92 R d92 , wherein the C 1-6  alkyl, C 2-6  alkenyl, C 2-6  alkynyl, phenyl, C 3-7  cycloalkyl, 5-6 membered heteroaryl, 4-7 membered heterocycloalkyl, phenyl-C 1-6  alkyl-, C 3-7  cycloalkyl-C 1-6  alkyl-, (5-6 membered heteroaryl)-C 1-6  alkyl-, and (4-7 membered heterocycloalkyl)-C 1-6  alkyl- of R 9A  are each optionally substituted with 1, 2, 3, or 4 independently selected R M  substituents; 
         each R a92 , R b92 , R c92 , and R d92  is independently selected from H, C 1-6  alkyl, C 16  haloalkyl, C 2-6  alkenyl, C 2-6  alkynyl, phenyl, C 3-7  cycloalkyl, 5-6 membered heteroaryl, 4-7 membered heterocycloalkyl, phenyl-C 1-6  alkyl-, C 3-7  cycloalkyl-C 1-6  alkyl-, (5-6 membered heteroaryl)-C 1-6  alkyl-, and (4-7 membered heterocycloalkyl)-C 1-6  alkyl-, wherein the C 1-6  alkyl, C 2-6  alkenyl, C 2-6  alkynyl, phenyl, C 3-7  cycloalkyl, 5-6 membered heteroaryl, 4-7 membered heterocycloalkyl, phenyl-C 1-6  alkyl-, C 3-7  cycloalkyl-C 1-6  alkyl-, (5-6 membered heteroaryl)-C 1-6  alkyl-, and (4-7 membered heterocycloalkyl)-C 1-6  alkyl- of R a92 , R b92 , R c92  and R d92  are each optionally substituted with 1, 2, 3, or 4 independently selected R M  substituents; 
         or, any R c92  and R d92 , attached to the same N atom, together with the N atom to which they are attached, form a 5-6 membered heteroaryl group or a 4-7 membered heterocycloalkyl group, wherein the 5-6 membered heteroaryl group or 4-7 membered heterocycloalkyl group is optionally substituted with 1, 2, 3, or 4 independently selected R M  substituents; 
         R 10N  is selected from H, C 1-6  alkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 1-6  haloalkyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, (4-10 membered heterocycloalkyl)-C 1-6  alkyl-, —C(O)R b10N , —C(O)NR c10N R d10N , —C(O)OR a10N , —C(═NR e10N )R b10 N, —C (═NR e10N )NR c10N R d10N , —C(═NCN)NR c10N R d10N , —C(NOR a10N )NR c10N , —S(O) 2 R b10N , —S(O)(═NR c10N )R d10N , and —S(O) 2 NR c10N R d10N  wherein the C 1-6  alkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl- and (4-10 membered heterocycloalkyl)-C 1-6  alkyl- of R 10N  are each optionally substituted with 1, 2, 3, 4, 5, 6, 7, or 8 independently selected R 10NA  substituents; 
         each R a10N , R b10N , R c10N , and R d10N  is independently selected from H, C 1-6  alkyl, C 1-6  haloalkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, and (4-10 membered heterocycloalkyl)-C 1-6  alkyl-, wherein the C 1-6  alkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, and (4-10 membered heterocycloalkyl)-C 1-6  alkyl- of R a10N , R b10N , R c10N , and R d10N  are each optionally substituted with 1, 2, 3, 4, 5, 6, 7, or 8 independently selected R 10NA  substituents; 
         or, any R c10N  and R d10N , attached to the same N atom, together with the N atom to which they are attached, form a 5-10 membered heteroaryl group or a 4-10 membered heterocycloalkyl group, wherein the 5-10 membered heteroaryl group or 4-10 membered heterocycloalkyl group is optionally substituted with 1, 2, 3, 4, 5, 6, 7, or 8 independently selected R 10NA  substituents; each R e10N  is independently selected from H, OH, CN, C 1-6  alkyl, C 1-6  alkoxy, C 1-6  haloalkyl, C 1-6  haloalkoxy, C 2-6  alkenyl, and C 2-6  alkynyl; 
         each R 10NA  is selected from H, D, halo, C 1-6  alkyl, C 1-6  haloalkyl, C 2-6  alkenyl, C 2-6  alkynyl, phenyl, C 3-7  cycloalkyl, 5-6 membered heteroaryl, 4-7 membered heterocycloalkyl, phenyl-C 1-6  alkyl-, C 3-7  cycloalkyl-C 1-6  alkyl-, (5-6 membered heteroaryl)-C 1-6  alkyl-, (4-7 membered heterocycloalkyl)-C 1-6  alkyl-, CN, NO 2 , —OR a10N2 , —SR a10N2 , —NHOR a10N2 , —C(O)R b10N2 , —C(O)NR c10N2 R d10N2 , —C(O)NR c10N2 (OR a10N2 ), —C(O)OR a10N2 , —OC(O)R b10N2 , OC(O)NR c10N2 R d10N2 , —NR c10N2 R d10N2 , —NR c10N2 NR c10N2 R d10N2 , —NR c10N2 C(O)R b10N2 , —NR c10N2 C(O)OR a10N2  and —NR c10N2 C(O)NR c10N2 R d10N2  wherein the C 1-6  alkyl, C 2-6  alkenyl, C 2-6  alkynyl, phenyl, C 3-7  cycloalkyl, 5-6 membered heteroaryl, 4-7 membered heterocycloalkyl, phenyl-C 1-6  alkyl-, C 3-7  cycloalkyl-C 1-6  alkyl-, (5-6 membered heteroaryl)-C 1-6  alkyl-, and (4-7 membered heterocycloalkyl)-C 1-6  alkyl- of R 10NA  are each optionally substituted with 1, 2, 3, or 4 independently selected R M  substituents; 
         each R a10N2 , R b10N2 , R c10N2 , and R d10N2  is independently selected from H, C 1-6  alkyl, C 1-6  haloalkyl, C 2-6  alkenyl, C 2-6  alkynyl, phenyl, C 3-7  cycloalkyl, 5-6 membered heteroaryl, 4-7 membered heterocycloalkyl, phenyl-C 1-6  alkyl-, C 3-7  cycloalkyl-C 1-6  alkyl-, (5-6 membered heteroaryl)-C 1-6  alkyl-, and (4-7 membered heterocycloalkyl)-C 1-6  alkyl-, wherein the C 1-6  alkyl, C 2-6  alkenyl, C 2-6  alkynyl, phenyl, C 3-7  cycloalkyl, 5-6 membered heteroaryl, 4-7 membered heterocycloalkyl, phenyl-C 1-6  alkyl-, C 3-7  cycloalkyl-C 1-6  alkyl-, (5-6 membered heteroaryl)-C 1-6  alkyl-, and (4-7 membered heterocycloalkyl)-C 1-6  alkyl- of R a10N2 , N b10N2 , R c10N2  and R d10N2  are each optionally substituted with 1, 2, 3, or 4 independently selected R M  substituents; 
         or, any R c10N2  and R d10N2 , attached to the same N atom, together with the N atom to which they are attached, form a 5-6 membered heteroaryl group or a 4-7 membered heterocycloalkyl group, wherein the 5-6 membered heteroaryl group or 4-7 membered heterocycloalkyl group is optionally substituted with 1, 2, 3, or 4 independently selected R M  substituents; 
         R 11N  is selected from H, C 1-6  alkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 1-6  haloalkyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, (4-10 membered heterocycloalkyl)-C 1-6  alkyl-, —C(O)R b11N , —C(O) NR   c11N R d11N , —C(O)OR a11N , —C(═NR e11N )R b11N , —C(═NR e11N )NR c11N R d11N , —C(═NCN)NR c11N R d11N , —C(═NOR a11N )NR c11N , —S(O) 2 R b11N , —S(O)(═NR c11N )R d11N , and —S(O) 2 NR c11N R d11N  wherein the C 1-6  alkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-10  cycloalkyl, 1 5-10 membered heteroaryl,4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl- and (4-10 membered heterocycloalkyl)-C 1-6  alkyl- of R 11N  are each optionally substituted with 1, 2, 3, 4, 5, 6, 7, or 8 independently selected R 11NA  substituents; 
         each R allN , R b11 N , R c11N, and R d11N  is independently selected from H, C 1-6  alkyl, C 1-6  haloalkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, and (4-10 membered heterocycloalkyl)-C 1-6  alkyl-, wherein the C 1-6  alkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, and (4-10 membered heterocycloalkyl)-C 1-6  alkyl- of R a11N , R b11N , R c11N , and R d11N  are each optionally substituted with 1, 2, 3, 4, 5, 6, 7, or 8 independently selected R 11NA  substituents; 
         or, any R c11N and R d11N , attached to the same N atom, together with the N atom to which they are attached, form a 5-10 membered heteroaryl group or a 4-10 membered heterocycloalkyl group, wherein the 5-10 membered heteroaryl group or 4-10 membered heterocycloalkyl group is optionally substituted with 1, 2, 3, 4, 5, 6, 7, or 8 independently selected R 11NA  substituents; 
         each R e11N  is independently selected from H, OH, CN, C u - 6  alkyl, C 1-6  alkoxy, C 1-6  haloalkyl, C 1-6  haloalkoxy, C 2-6  alkenyl, and C 2-6  alkynyl; 
         each R 11NA  is selected from H, D, halo, C 1-6  alkyl, C 1-6  haloalkyl, C 2-6  alkenyl, C 2-6  alkynyl, phenyl, C 3-7  cycloalkyl, 5-6 membered heteroaryl, 4-7 membered heterocycloalkyl, phenyl-C 1-6  alkyl-, C 3-7  cycloalkyl-C 1-6  alkyl-, (5-6 membered heteroaryl)-C 1-6  alkyl-, (4-7 membered heterocycloalkyl)-C 1-6  alkyl-, CN, NO 2 , —OR a11N2 , —SR a11N2 , —NHOR a11N2 , —C(O)R b11N2 , —C(O)NR c11N2 R d11N , —C(O)NR c11N2 (OR a11N2 ), —C(O)OR a11N2 , —OC(O)R b11N2 , —OC(O)NR c11N2 R d11N2 , —NR c11N2 R d11N2 , —NR c11N2 NR c11N2 R d11N2 , —NR c11N2 C(O)R b11N2 , —NR c11N2 C(O)OR a11N2 , and —NR c11N2 C(O) NR   c11N2 R d11N2 ; wherein the C 1-6  alkyl, C 2-6  alkenyl, C 2-6  alkynyl, phenyl, C 3-7  cycloalkyl, 5-6 membered heteroaryl, 4-7 membered heterocycloalkyl, phenyl-C 1-6  alkyl-, C 3-7  cycloalkyl-C 1-6  alkyl-, (5-6 membered heteroaryl)-C 1-6  alkyl-, and (4-7 membered heterocycloalkyl)-C 1-6  alkyl- of R 11NA  are each optionally substituted with 1, 2, 3, or 4 independently selected R M  substituents; 
         each R a11N2 , R b11N2 , R c11N2  and R d11N2  is independently selected from H, C 1-6  alkyl, C 1-6  haloalkyl, C 2-6  alkenyl, C 2-6  alkynyl, phenyl, C 3-7  cycloalkyl, 5-6 membered heteroaryl, 4-7 membered heterocycloalkyl, phenyl-C 1-6  alkyl-, C 3-7  cycloalkyl-C 1-6  alkyl-, (5-6 membered heteroaryl)-C 1-6  alkyl-, and (4-7 membered heterocycloalkyl)-C 1-6  alkyl-, wherein the C 1-6  alkyl, C 2-6  alkenyl, C 2-6  alkynyl, phenyl, C 3-7  cycloalkyl, 5-6 membered heteroaryl, 4-7 membered heterocycloalkyl, phenyl-C 1-6  alkyl-, C 3-7  cycloalkyl-C 1-6  alkyl-, (5-6 membered heteroaryl)-C 1-6  alkyl-, and (4-7 membered heterocycloalkyl)-C 1-6  alkyl- of R a11N2 , R b11N2 , R c11N2 , and R d11N2  are each optionally substituted with 1, 2, 3, or 4 independently selected R M  substituents; 
         or, any R c11N2  and R d11N2  attached to the same N atom, together with the N atom to which they are attached, form a 5-6 membered heteroaryl group or a 4-7 membered heterocycloalkyl group, wherein the 5-6 membered heteroaryl group or 4-7 membered heterocycloalkyl group is optionally substituted with 1, 2, 3, or 4 independently selected R M  substituents; 
         each R 11  is independently selected from H, D, halo, C 1-6  alkyl, C 1-6  haloalkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, (4-10 membered heterocycloalkyl)-C 1-6  alkyl-, CN, NO 2 , —OR a111 , —SR a111 , —NHOR a111 , —C(O)R b111 , —C(O)NR c111 R d111 ) —C(O)NR c111 (OR a111 ), —C(O)OR a111 , —OC(O)R b111 , OC(O)NR c111 R d111 , —NR c111 R d111 , —NR c111 NR c111 R d111 , —NR c111 C(O)R b111 , —NR c111 C(O)OR a111 , and —NR c111 C(O)NR c111 R d111 , wherein the C 1-6  alkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, and (4-10 membered heterocycloalkyl)-C 1-6  alkyl- of R 11  are each optionally substituted with 1, 2, 3, 4, 5, 6, 7, or 8 independently selected R 11A  substituents; 
         or, alternatively, two R 11  groups together form an oxo group; 
         each R a11 , R b111 , and R c111 , is independently selected from H, C 1-6  alkyl, C 1-6  haloalkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, and (4-10 membered heterocycloalkyl)-C 1-6  alkyl-, wherein the C 1-6  alkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, and (4-10 membered heterocycloalkyl)-C 1-6  alkyl- of R a111 , R b111 , R c111 , and R d111  are each optionally substituted with 1, 2, 3, 4, 5, 6, 7, or 8 independently selected R 11A  substituents; 
         or, any R a11  and R d111 , attached to the same N atom, together with the N atom to which they are attached, form a 5-10 membered heteroaryl group or a 4-10 membered heterocycloalkyl group, wherein the 5-10 membered heteroaryl group or 4-10 membered heterocycloalkyl group is optionally substituted with 1, 2, 3, 4, 5, 6, 7, or 8 independently selected R 11A  substituents; and 
         each R 11A  is selected from H, D, halo, C 1-6  alkyl, C 1-6  haloalkyl, C 2-6  alkenyl, C 2-6  alkynyl, phenyl, C 3-7  cycloalkyl, 5-6 membered heteroaryl, 4-7 membered heterocycloalkyl, phenyl-C 1-6  alkyl-, C 3-7  cycloalkyl-C 1-6  alkyl-, (5-6 membered heteroaryl)-C 1-6  alkyl-, (4-7 membered heterocycloalkyl)-C 1-6  alkyl-, CN, NO 2 , —OR a112 , —SR a112 , —NHOR a112 , —C(O)R b112 , —C(O)NR c112 R d112 , —C(O)NR c112 (OR a112 ), —C(O)OR a112 , —OC(O)R b112 , —OC(O)NR c112 R d112 , —NR c112   R   d112 , —NR c112 , —NR c112 R d112 , —NR c112 C(O)R b112 , —NR c112 C(O)OR a112 , and —NR c112 C(O)NR c112 R d112 , wherein the C 1-6  alkylm C 2-6  alkenyl, C 2-6  alkynyl, phenyl, C 3-7  cycloalkyl, 5-6 membered heteroaryl, 4-7 membered heterocycloalkyl, phenyl-C 1-6  alkyl-, C 3-7  cycloalkyl-C 1-6  alkyl-, (5-6 membered heteroaryl)-C1.6 alkyl-, and (4-7 membered heterocycloalkyl)-C 1-6  alkyl- of R 11A  are each optionally substituted with 1, 2, 3, or 4 independently selected R M  substituents; and 
         each R a112 , R b112 , R c112 , and R d112  is independently selected from H, C 1-6  alkyl, C 1-6  haloalkyl, C 2-6  alkenyl, C 2-6  alkynyl, phenyl, C 3-7  cycloalkyl, 5-6 membered heteroaryl, 4-7 membered heterocycloalkyl, phenyl-C 1-6  alkyl-, C 3-7  cycloalkyl-C 1-6  alkyl-, (5-6 membered heteroaryl)-C 1-6  alkyl-, and (4-7 membered heterocycloalkyl)-C 1-6  alkyl-, wherein the C 1-6  alkyl, C 2-6  alkenyl, C 2-6  alkynyl, phenyl, C 3-7  cycloalkyl, 5-6 membered heteroaryl, 4-7 membered heterocycloalkyl, phenyl-C 1-6  alkyl-, C 3-7  cycloalkyl-C 1-6  alkyl-, (5-6 membered heteroaryl)-C 1-6  alkyl-, and (4-7 membered heterocycloalkyl)-C 1-6  alkyl- of R a112 , R b112 , R c112  and R d112  are each optionally substituted with 1, 2, 3, or 4 independently selected R M  substituents; 
         or, any R c112  and R d112 , attached to the same N atom, together with the N atom to which they are attached, form a 5-6 membered heteroaryl group or a 4-7 membered heterocycloalkyl group, wherein the 5-6 membered heteroaryl group or 4-7 membered heterocycloalkyl group is optionally substituted with 1, 2, 3, or 4 independently selected R M  substituents. 
       
     
     
         37 . The method of  claim 36 , wherein the compound of Formula (IIu), or pharmaceutically acceptable salt thereof, is a selective inhibitor for PI3Kγ over one or more of PI3Kα, PI3Kβ, and PI3Kδ. 
     
     
         38 . A method of treating a disease or disorder in a patient, wherein the disease or disorder is associated with abnormal expression or activity of PI3Kγ kinase, comprising administering to the patient a therapeutically effective amount of a compound of Formula (IIu): 
       
         
           
           
               
               
           
         
         or a pharmaceutically acceptable salt thereof, wherein:
 Z is CZ 1  or N; 
 Z 1  and R 12  are each independently selected from H, D, OH, NO 2 , CN, halo, C 1-3  alkyl, C 2-3  alkenyl, C 2-3  alkynyl, C 1-3  haloalkyl, cyano-C 1-3  alkyl, HO—C 1-3  alkyl, C 1-3  alkoxy-C 1-3  alkyl, C 3-6  cycloalkvl, C 1-3  alkoxy, C 1-3  haloalkoxy, amino, C 1-3  alkylamino, alkyl)amino, thio, C 1-3  alkylthio, alkylsulfinyl, alkylsulfonyl, carbamyl, alkylcarbamyl, di(C 1-3  alkyl)carbamyl, carboxy, C 1-3  alkylcarbonyl, C1-4 alkoxycarbonyl, alkylcarbonylamino, C 1-3  alkoxycarbonylamino, C 1-3  alkylcarbonyloxy, aminocarbonyloxy, C 1-3  alkylaminocarbonyloxy, alkyl)aminocarbonyloxy, C 1-3  alkylsulfonylamino, aminosulfonyl, C 1-3  alklaminosulfon 1 di(C 1-3  alk aminosulfon 1 aminosulfon lamino C 1-3  alkylaminosulfonylamino, alkyl)aminosulfonylamino, aminocarbonylamino, C 1-3  alkylaminocarbonylamino, and di(C 1-3  alkyl)aminocarbonylamino; 
 
         R i  is selected from H, D, halo, C 1-6  alkyl, C 1-6  haloalkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6 alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, (4-10 membered heterocycloalkyl)-C 1-6  alkyl-, CN, NO 2 , —OR a1 , —SR a1 , —NHOR a1 , —C(O)R b1 , —C(O) NR   c1 R d1 , —C(O)NR c1 (OR a1 ), —C(O)OR a1 , —OC(O)R b1 , —OC(O)NR c1 R d1 , —NR c1 R d1 , —NR c1 NR c1 R d1 , —NR c1 C(O)R b1 , —NR c1 C(O)OR a1 , and —NR c1 C(O)NR c1 R d1 , wherein the C 1-6  alkyl, C 2-6 alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1 -6 alkyl-, and (4-10 membered heterocycloalkyl)-C 1-6  alkyl- of R 1  are each optionally substituted with 1, 2, 3, 4, 5, 6, 7, or 8 independently selected R 1A  substituents; 
         each R a1 , R b1 , R c1 , and R d1  is independently selected from H, C 1-6  alkyl, C 1-6  haloalkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, and (4-10 membered heterocycloalkyl)-C 1-6  alkyl-, wherein the C 1-6  alkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, and (4-10 membered heterocycloalkyl)-C 1-6  alkyl- of R a1 , R b1 , R c1  and R d1  are each optionally substituted with 1, 2, 3, 4, 5, 6, 7, or 8 independently selected R 1A  substituents; 
         or, any R c1  and R d1 , attached to the same N atom, together with the N atom to which they are attached, form a 5-10 membered heteroaryl group or a 4-10 membered heterocycloalkyl group, wherein the 5-10 membered heteroaryl group or 4-10 membered heterocycloalkyl group is optionally substituted with 1, 2, 3, 4, 5, 6, 7, or 8 independently selected R 1A  substituents; 
         each R 1A  is selected from H, D, halo, C 1-6  alkyl, C 1-6  haloalkyl, C 2-6  alkenyl, C 2-6  alkynyl, aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, (4-10 membered heterocycloalkyl)-C 1-6  alkyl-, CN, NO 2 , —OR a111 , —SR a11 , —NHOR a11 , —C(O)R b11 , —C(O)NR c11 R d11 , —C(O)NR c11 (OR a11 ), —C(O)OR a11 , —OC(O)R b11 , —OC(O)NR c11 R d11 , —NR c11 R d11 , —NR c11 NR c11 R d11 , —NR c11 C(O)R b11 , —NR c11 C(O)OR a11 , and —NR c11 C(O)NR c11 R d11 , wherein the C 1-6  alkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, and (4-10 membered heterocycloalkyl)-C 1-6  alkyl- of R 1A  are each optionally substituted with 1, 2, 3, 4, 5, 6, 7, or 8 independently selected R M  substituents; 
         each R a11 , R b11 , R c11 , and R d11  is independently selected from H, C 1-6  alkyl, C 1-6  haloalkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, and (4-10 membered heterocycloalkyl)-C h6  alkyl-, wherein the C 1-6  alkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, and (4-10 membered heterocycloalkyl)-C 1-6  alkyl- of R a11 , R b11 , R c11  and R d11  are each optionally substituted with 1, 2, 3, 4, 5, 6, 7, or 8 independently selected R M  substituents; 
         or, any R c11  and R d11 , attached to the same N atom, together with the N atom to which they are attached, form a 5-10 membered heteroaryl group or a 4-10 membered heterocycloalkyl group, wherein the 5-10 membered heteroaryl group or 4-10 membered heterocycloalkyl group is optionally substituted with 1, 2, 3, 4, 5, 6, 7, or 8 independently selected R M  substituents; 
         each R M  is independently selected from D, OH, NO 2 , CN, halo, C 1-3  alkyl, C 2-3  alkenyl, C 2-3  alkynyl, C 1-3  haloalkyl, cyano-C 1-3  alkyl, HO—C 1-3  alkyl, C 1-3  alkoxy-C 1-3  alkyl, C 3-6  cycloalkyl, C 1-3  alkoxy, C 1-3  haloalkoxy, amino, C 1-3  alkylamino, di(C 1-3  alkyl)amino, thio, C 1-3  alkylthio, C 1-3  alkylsulfinyl, C 1-3  alkylsulfonyl, carbamyl, C 1-3  alkylcarbamyl, di(C 1-3  alkyl)carbamyl, carboxy, C 1-3  alkylcarbonyl, alkoxycarbonyl, C 1-3  alkylcarbonylamino, C 1-3  alkoxycarbonylamino, C 1-3  alkylcarbonyloxy, aminocarbonyloxy, C 1-3  alkylaminocarbonyloxy, di(C 1-3  alkyl)aminocarbonyloxy, C 1-3  alkylsulfonylamino, aminosulfonyl, C 1-3  alkylaminosulfonyl, alkyl)aminosulfonyl, aminosulfonylamino, C 1-3  alkylaminosulfonylamino, alkyl)aminosulfonylamino, aminocarbonylamino, C 1-3  alkylaminocarbonylamino, and di(C 1-3  alkyl)aminocarbonylamino; 
         R 2  is selected from H, D, halo, C 1-6  alkyl, C 1-6  haloalkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, (4-10 membered heterocycloalkyl)-C 1-6  alkyl-, CN, NO 2 , —OR a2 , —SR a2 , —NHOR a2 , —C(O)R b2 , —C(O) NR   c2 R d2 , —C(O)NR c2 (OR a2 ), —C(O)OR a2 , —OC(O)R b2 , —OC(O)NR c2 R d2 , —NR c2 R d2 , —NR c2 NR c2 R d2 , —NR c2 C(O)R b2 , —NR c2 (O)OR a2 , and —NR c2 C(O)NR c2 R d2 , wherein the C 1-6  alkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, and (4-10 membered heterocycloalkyl)-C 1-6  alkyl- of R 2  are each optionally substituted with 1, 2, 3, 4, 5, 6, 7, or 8 independently selected R 2A  substituents; 
         each R a2 , R b2 , R c2 , and R d2  is independently selected from H, C 1-6  alkyl, C 1-6  haloalkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, and (4-10 membered heterocycloalkyl)-C 1-6  alkyl-, wherein the C 1-6  alkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, and (4-10 membered heterocycloalkyl)-C 1-6  alkyl- of R a2 , R b2 , R c2  and R d2  are each optionally substituted with 1, 2, 3, 4, 5, 6, 7, or 8 independently selected R 2A  substituents; 
         or, any R c2  and R d2 , attached to the same N atom, together with the N atom to which they are attached, form a 5-10 membered heteroaryl group or a 4-10 membered heterocycloalkyl group, wherein the 5-10 membered heteroaryl group or 4-10 membered heterocycloalkyl group is optionally substituted with 1, 2, 3, 4, 5, 6, 7, or 8 independently selected R 2A  substituents; 
         each R 2A  is selected from H, D, halo, C 1-6  alkyl, C 1-6  haloalkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-11 ) cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, (4-10 membered heterocycloalkyl)-C 1-6  alkyl-, CN, NO 2 , —OR a21 , —SR a21 , —NHOR a21 , —C(O)R b21 , —C(O)NR c21 R d21 , —C(O)NR c21 (OR a21 ), —C(O)OR a21 , —OC(O)R b21 , —OC(O)NR c21 R d21 , —NR c21 R d21 , —NR c21 NR c21 R d21 , —NR c21 C(O)R b21 , —NR c21 C(O)OR a21 , and —NR c21 C(O)NR c21 R d21 , wherein the C 1-6  alkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-11 ) aryl-C 1-6  alkyl-, C 3-11 ) cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, and (4-10 membered heterocycloalkyl)-C 1-6  alkyl- of R 2A  are each optionally substituted with 1, 2, 3, 4, 5, 6, 7, or 8 independently selected R M  substituents; 
         each R a21 , R b21 , R c21 , and R d21  is independently selected from H, C 1-6  alkyl, C 1-6  haloalkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, and (4-10 membered heterocycloalkyl)-C 1-6  alkyl-, wherein the C 1-6  alkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, and (4-10 membered heterocycloalkyl)-C 1-6  alkyl- of R a21 , R b21 , R c21  and R d21  are each optionally substituted with 1, 2, 3, 4, 5, 6, 7, or 8 independently selected R M  substituents; 
         or, any R c21  and R d21 , attached to the same N atom, together with the N atom to which they are attached, form a 5-10 membered heteroaryl group or a 4-10 membered heterocycloalkyl group, wherein the 5-10 membered heteroaryl group or 4-10 membered heterocycloalkyl group is optionally substituted with 1, 2, 3, 4, 5, 6, 7, or 8 independently selected R M  substituents; 
         or alternatively, R 1  and R 2 , taken together with the carbon atoms to which they are attached form a monocyclic 4-7 membered cycloalkyl ring, a phenyl ring, a monocyclic 4-7 membered heterocycloalkyl ring, or a monocyclic 5-6 membered heteroaryl ring, each of which is optionally substituted by 1, 2, 3, 4, 5, 6, 7 or 8 independently selected R 1A  groups; 
         R 6  is selected from H, D, halo, C 1-6  alkyl, C 1-6  haloalkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C6-11) aryl-C 1-3  6 alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, (4-10 membered heterocycloalkyl)-C 1-6  alkyl-, CN, NO 2 , —OR a6 , —SR a6 , —NHOR a6 , —C(O)R b6 , —C(O)NR c6   R   d6 , —C(O)NR c6 (OR a6 ), —C(O)OR a6 , —OC(O)R b6 , —OC(O)NR c6 R d6 , —NR c6 R d6 , —NR c6 NR c6 R d6 , —NR c6 C(O)R b6 , NR c6 C(O)OR a6 , —NR c6 C(O)NR c6 R d6 , —C(═NOH)R b6 , —C(═NCN)R b6 , —C(═NR e6 )NR c6 R d6 , —NR c6 C(═NR e6 )NR c6 R d6 , —NR c6 C(═NOH)R b6 , —NR c6 C(═NCN)NR c6 R d6 , —NR c6 C(═NR e6 )R b6 , —NR c6  S(O)NR c6 R d6 , —NR c6 S(O) 2 R b6 , —NR c6 S(O)(═NR e6 )R b6 , —NR c6 S(O) 2 NR c6 R d6 , S(O)R b6 , —S(O)NR c6 R d6 , —S(O) 2 R b6 , —S(O) 2 NR c6 R d6 , —S(O)(═NR e6 )R b6 , —N═S(O)R a6 R b6 , —OS(O)(═OS(O) 2 R b6  and —SF 5 , wherein the C 1-6  alkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C6-11) aryl-C 1-6  alkyl-, C3-11) cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, and (4-10 membered heterocycloalkyl)-C 1-6  alkyl- of R 6  are each optionally substituted with 1, 2, 3, 4, 5, 6, 7, or 8 independently selected R 6A  substituents; 
         each R a6 , R b6 , R c6 , R d6 , and R e6 , is independently selected from H, C 1-6  alkyl, C 1-6  haloalkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, and (4-10 membered heterocycloalkyl)-C 1-6  alkyl-, wherein the C 1-6  alkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, and (4-10 membered heterocycloalkyl)-C 1-6  alkyl- of R a6 , R b6 , R c6 , R d6 , and R e6  are each optionally substituted with 1, 2, 3, 4, 5, 6, 7, or 8 independently selected R 6A  substituents; 
         or, any R cb  and R d6 , attached to the same N atom, together with the N atom to which they are attached, form a 5-10 membered heteroaryl group or a 4-10 membered heterocycloalkyl group, wherein the 5-10 membered heteroaryl group or 4-10 membered heterocycloalkyl group is optionally substituted with 1, 2, 3, 4, 5, 6, 7, or 8 independently selected R 6A  substituents; 
         each R 6A  is selected from H, D, halo, C 1-6  alkyl, C 1-6  haloalkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, (4-10 membered heterocycloalkyl)-C 1-6  alkyl-, CN, NO 2 , —OR a61 , —NHOR a61 , —C(O)R b61 , C(O)NR c61 R d61 , —C(O)NR c61 (OR a61 ), —C(O)OR a61 , —OC(O) Rb61 , —OC(O)NR c61 R d61 NR c61 R d61 , —NR c61 NR c61 R d61 , —NR c61 C(O)R b61 , —NR c61 C(O)OR a61 and —NR c61 C(O)NR c61 R d61 , alkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, and (4-10 membered heterocycloalkyl)-C 1-6  alkyl- of R 6A  are each optionally substituted with 1, 2, 3, 4, 5, 6, 7, or 8 independently selected R M  substituents; 
         each R a61 , R b61 , R c61 , and R d61  is independently selected from H, C 1-6  alkyl, C 1-6  haloalkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, and (4-10 membered heterocycloalkyl)-C 1-6  alkyl-, wherein the C 1-6  alkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, and (4-10 membered heterocycloalkyl)-C 1-6  alkyl- of R a61 , R b61 , R c61  and R d61  are each optionally substituted with 1, 2, 3, 4, 5, 6, 7, or 8 independently selected R M  substituents; 
         or, any R c61  and R d61 , attached to the same N atom, together with the N atom to which they are attached, form a 5-10 membered heteroaryl group or a 4-10 membered heterocycloalkyl group, wherein the 5-10 membered heteroaryl group or 4-10 membered heterocycloalkyl group is optionally substituted with 1, 2, 3, 4, 5, 6, 7, or 8 independently selected R M  substituents; 
         X 9  is —NR 9N  or —C(R 9 ) 2 ; 
         X 11  is —NR 11N  or —C(R 11 ) 2 ; 
         R 9N  is selected from H, C 1-6  alkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 1-6  haloalkyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, (4-10 membered heterocycloalkyl)-C 1-6  alkyl-, —C(O)R b9N , —C(O)NR c9N R d9N , —C(O)OR a9N , —C(═NR e9N )R b9N , —C(═NR e9N )NR c9N R d9N , —C(═NCN)NR c9N R d9N , —C(═NOR a9N )NR c9N , S(O) 2 R b9N , —S(O)(═R c9N )R d9N , and —S(O) 2 NR c9N R s9N , wherein the C 1-6  alkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl- and (4-10 membered heterocycloalkyl)-C 1-6  alkyl- of R 9N  are each optionally substituted with 1, 2, 3, 4, 5, 6, 7, or 8 independently selected R 9NA  substituents; 
         each R a9N , R b9N , R c9N , and R d9N  is independently selected from H, C 1-6  alkyl, C 1-6  haloalkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, and (4-10 membered heterocycloalkyl)-C 1-6  alkyl-, wherein the C 1-6  alkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, and (4-10 membered heterocycloalkyl)-C 1-6 alkyl- of R a9N , R b9N , R c9N , and R d9N  are each optionally substituted with 1, 2, 3, 4, 5, 6, 7, or 8 independently selected R 9NA  substituents; 
         or, any R c9N  and R d9N , attached to the same N atom, together with the N atom to which they are attached, form a 5-10 membered heteroaryl group or a 4-10 membered heterocycloalkyl group, wherein the 5-10 membered heteroaryl group or 4-10 membered heterocycloalkyl group is optionally substituted with 1, 2, 3, 4, 5, 6, 7, or 8 independently selected R 9NA  substituents; 
         each R e9N  is independently selected from H, OH, CN, C 1-6  alkyl, C 1-6  alkoxy, C 1-6  haloalkyl, C 1-6  haloalkoxy, C 2-6  alkenyl, and C 2-6  alkynyl; each R 9NA  is selected from H, D, halo, C 1-6  alkyl, C 1-6  haloalkyl, C 2-6  alkenyl, C 2-6  alkynyl, phenyl, C 3-7  cycloalkyl, 5-6 membered heteroaryl, 4-7 membered heterocycloalkyl, phenyl-C 1-6  alkyl-, C 3-7  cycloalkyl-C 1-6  alkyl-, (5-6 membered heteroaryl)-C 1-6  alkyl-, (4-7 membered heterocycloalkyl)-C 1-6  alkyl-, CN, NO 2 , —OR a9N2 , —SR a9N2 , —NHOR a9N2  —C(O)R b9N2 , C(O)NR C9N2  R d9N2 , —C(O)NR C9N2  (OR a9N2 ), —C(O)OR a9N2 , —OC(O)R b9N2 , —OC(O) NRc9 N 2 R d9N2 , NR C9N2  R d9N2 , —NR C9N2 NR C9N2 R d9N2 , —NR C9N2 C(O)R b9N2 , —NR C9N2 C(O)OR a9N2 , and —NR c9N2 C(O) NR   c9N2 R d9N2 ; wherein the C 1-6  alkyl, C 2-6  alkenyl, C 2-6  alkynyl, phenyl, C 3-7  cycloalkyl, 5-6 membered heteroaryl, 4-7 membered heterocycloalkyl, phenyl-C 1-6  alkyl-, C 3-7  cycloalkyl-C 1-6  alkyl-, (5-6 membered heteroaryl)-C 1-6  alkyl-, and (4-7 membered heterocycloalkyl)-C 1-6  alkyl- of R 9NA  are each optionally substituted with 1, 2, 3, or 4 independently selected R M  substituents; 
         each R a9N2 , R b9N2 , R c9N2 , and R d9N2  is independently selected from H, C 1-6  alkyl, C 1-6  haloalkyl, C 2-6  alkenyl, C 2-6  alkynyl, phenyl, C 3-7  cycloalkyl, 5-6 membered heteroaryl, 4-7 membered heterocycloalkyl, phenyl-C 1-6  alkyl-, C 3-7  cycloalkyl-C 1-6  alkyl-, (5-6 membered heteroaryl)-C 1-6  alkyl-, and (4-7 membered heterocycloalkyl)-C 1-6  alkyl-, wherein the C 1-6  alkyl, C 2-6  alkenyl, C 2-6  alkynyl, phenyl, C 3-7  cycloalkyl, 5-6 membered heteroaryl, 4-7 membered heterocycloalkyl, phenyl-C 1-6  alkyl-, C 3-7  cycloalkyl-C 1-6  alkyl-, (5-6 membered heteroaryl)-C 1-6  alkyl-, and (4-7 membered heterocycloalkyl)-C 1-6  alkyl- of R a9N2 , R b9N2 , R c9N2  and R d9N2  are each optionally substituted with 1, 2, 3, or 4 independently selected R M  substituents; 
         or, any R c9N2  and R d9N2 , attached to the same N atom, together with the N atom to which they are attached, form a 5-6 membered heteroaryl group or a 4-7 membered heterocycloalkyl group, wherein the 5-6 membered heteroaryl group or 4-7 membered heterocycloalkyl group is optionally substituted with 1, 2, 3, or 4 independently selected R M  substituents; 
         each R 9  is independently selected from H, D, halo, C 1-6  alkyl, C 1-6  haloalkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, (4-10 membered heterocycloalkyl)-C 1-6  alkyl-, CN, NO 2 , —OR a91 , —SR a91 , —NHOR a91 , —C(O)R b91 , —C(O)NR c91 R d91 , —C(O)NR c91 (OR a91 ), —C(O)OR a91 , and —NR c91 C(O)NR c91 R d91 , NR c91 R d91 , —NR c91 NR c91 R d91 , —NR c91 C(O)R b91 , —NR c91 C(O)OR a91 , and —NR c91 C(O)NR c91 R d91 , wherein the C 1-6  alkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, and (4-10 membered heterocycloalkyl)-C 1-6  alkyl- of R 9  are each optionally substituted with 1, 2, 3, 4, 5, 6, 7, or 8 independently selected R 9A  substituents; 
         or, alternatively, two R 9  groups together form an oxo group; 
         each R a91 , R b91 , R c91 , and R d91  is independently selected from H, C 1-6  alkyl, C 1-6  haloalkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, and (4-10 membered heterocycloalkyl)-C h6  alkyl-, wherein the C 1-6  alkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, and (4-10 membered heterocycloalkyl)-C 1-6  alkyl- of R a91 , R b91 , R c91  and R d91  are each optionally substituted with 1, 2, 3, 4, 5, 6, 7, or 8 independently selected R 9A  substituents; 
         or, any R c91  and R d91 , attached to the same N atom, together with the N atom to which they are attached, form a 5-10 membered heteroaryl group or a 4-10 membered heterocycloalkyl group, wherein the 5-10 membered heteroaryl group or 4-10 membered heterocycloalkyl group is optionally substituted with 1, 2, 3, 4, 5, 6, 7, or 8 independently selected R 9A  substituents; 
         each R 9A  is selected from H, D, halo, C 1-6  alkyl, C 1-6  haloalkyl, C 2-6  alkenyl, C 2-6  alkynyl, phenyl, C 3-7  cycloalkyl, 5-6 membered heteroaryl, 4-7 membered heterocycloalkyl, phenyl-C 1-6  alkyl-, C 3-7  cycloalkyl-C 1-6  alkyl-, (5-6 membered heteroaryl)-C 1-6  alkyl-, (4-7 membered heterocycloalkyl)-C 1-6  alkyl-, CN, NO 2 , —OR a92 , —SR a92 , —NHOR a92 , —C(O)R b92 , —C(O)NR c92 R d92 , —C(O)NR c92 (OR a92 ), —C(O)OR a92 , —OC(O)R b92 , —OC(O)NR c92 R d92 NR c92 R d92 , —NR c92 NR c92 R d92 , —NR c92 C(O)R b92 , —NR c92 C(O)OR a92 , and —NR c92 C(O)NR c92 R d92 , wherein the C 1-6  alkyl, C 2-6  alkenyl, C 2-6  alkynyl, phenyl, C 3-7  cycloalkyl, 5-6 membered heteroaryl, 4-7 membered heterocycloalkyl, phenyl-C 1-6  alkyl-, C 3-7  cycloalkyl-C 1-6  alkyl-, (5-6 membered heteroaryl)-C 1-6  alkyl-, and (4-7 membered heterocycloalkyl)-C 1-6  alkyl- of R 9A  are each optionally substituted with 1, 2, 3, or 4 independently selected R M  substituents; 
         each R a92 , R b92 , R c92 , and R d92  is independently selected from H, C 1-6  alkyl, C 1-6  haloalkyl, C 2-6  alkenyl, C 2-6  alkynyl, phenyl, C 3-7  cycloalkyl, 5-6 membered heteroaryl, 4-7 membered heterocycloalkyl, phenyl-C 1-6  alkyl-, C 3-7  cycloalkyl-C 1-6  alkyl-, (5-6 membered heteroaryl)-C 1-6  alkyl-, and (4-7 membered heterocycloalkyl)-C 1-6  alkyl-, wherein the C 1-6  alkyl, C 2-6  alkenyl, C 2-6  alkynyl, phenyl, C 3-7  cycloalkyl, 5-6 membered heteroaryl, 4-7 membered heterocycloalkyl, phenyl-C 1-6  alkyl-, C 3-7  cycloalkyl-C 1-6  alkyl-, (5-6 membered heteroaryl)-C 1-6  alkyl-, and (4-7 membered heterocycloalkyl)-C 1-6  alkyl- of R a92 , R b92 , R c92  and R d92  are each optionally substituted with 1, 2, 3, or 4 independently selected R M  substituents; 
         or, any R c92  and R d92 , attached to the same N atom, together with the N atom to which they are attached, form a 5-6 membered heteroaryl group or a 4-7 membered heterocycloalkyl group, wherein the 5-6 membered heteroaryl group or 4-7 membered heterocycloalkyl group is optionally substituted with 1, 2, 3, or 4 independently selected R M  substituents; 
         R 10N  is selected from H, C 1-6  alkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 1-6  haloalkyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, (4-10 membered heterocycloalkyl)-C 1-6  alkyl-, —C(O)R b10N , —C(O)NR c10N R d10N , —C(O)OR a10N , —C(═NR e10N )R b10N , C(═NR e10N )NR c10N R d10N , —C(═NCN)NR c10N R d10N (═NOR a10N )NR c10N , —S(O) 2 R b10N , S(O)(═NR c10N )R d10N , and —S(O) 2 NR c10N R d10N  wherein the C 1-6  alkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl- and (4-10 membered heterocycloalkyl)-C 1-6  alkyl- of R 10N  are each optionally substituted with 1, 2, 3, 4, 5, 6, 7, or 8 independently selected R 10NA  substituents; 
         each R a10N , R b10N , R c10N , and R d10N  is independently selected from H, C 1-6  alkyl, C 1-6  haloalkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, and (4-10 membered heterocycloalkyl)-C 1-6  alkyl-, wherein the C 1-6  alkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, and (4-10 membered heterocycloalkyl)-C 1-6  alkyl- of R a10N , R b10N , R c10N , and R d10N  are each optionally substituted with 1, 2, 3, 4, 5, 6, 7, or 8 independently selected R 10NA  substituents; 
         or, any R c10N  and R d10N , attached to the same N atom, together with the N atom to which they are attached, form a 5-10 membered heteroaryl group or a 4-10 membered heterocycloalkyl group, wherein the 5-10 membered heteroaryl group or 4-10 membered heterocycloalkyl group is optionally substituted with 1, 2, 3, 4, 5, 6, 7, or 8 independently selected R 10NA  substituents; 
         each R e10N  is independently selected from H, OH, CN, C 1-6  alkyl, C i-6  alkoxy, C 1-6  haloalkyl, C 1-6  haloalkoxy, C 2-6  alkenyl, and C 2-6  alkynyl; 
         each R 10NA  is selected from H, D, halo, C 1-6  alkyl, C 1-6  haloalkyl, C 2-6  alkenyl, C 2-6  alkynyl, phenyl, C 3-7  cycloalkyl, 5-6 membered heteroaryl, 4-7 membered heterocycloalkyl, phenyl-C 1-6  alkyl-, C 3-7  cycloalkyl-C 1-6  alkyl-, (5-6 membered heteroaryl)-C 1-6  alkyl-, (4-7 membered heterocycloalkyl)-C 1-6  alkyl-, CN, NO 2 , —OR a10N2 , —SR a10N2 , —NHOR a10N2 , —C(O)R b10N2  —C(O)NR c10N2 R d10N2 , —C(O)NR c10N2 ( OR   a10N2 ), —C(O)OR a10N2 , —OC(O)R b10N2 , —OC(O)NR c10N2 R d10N2 , —NR c10N2 R d10N2 , —NR c10NR NR c10N2 R d10N2 , —NR c10N2 C(O)R b10N2 , —NR c10N2 C(O)OR a10N2 , and —NR c10N2 C(O)NR c10N2 R d10N2 , wherein the C 1-6  alkyl, C 2-6  alkenyl, C 2-6  alkynyl, phenyl, C 3-7  cycloalkyl, 5-6 membered heteroaryl, 4-7 membered heterocycloalkyl, phenyl-C 1-6  alkyl-, C 3-7  cycloalkyl-C 1-6  alkyl-, (5-6 membered heteroaryl)-C 1-6  alkyl-, and (4-7 membered heterocycloalkyl)-C 1-6  alkyl- of R 10NA  are each optionally substituted with 1, 2, 3, or 4 independently selected R M  substituents; 
         each R a10N2 , R b10N2 , R c10N2 , and R d10N2  is independently selected from H, C 1-6  alkyl, C 1-6  haloalkyl, C 2-6  alkenyl, C 2-6  alkynyl, phenyl, C 3-7  cycloalkyl, 5-6 membered heteroaryl, 4-7 membered heterocycloalkyl, phenyl-C 1-6  alkyl-, C 3-7  cycloalkyl-C 1-6  alkyl-, (5-6 membered heteroaryl)-C 1-6  alkyl-, and (4-7 membered heterocycloalkyl)-C 1-6  alkyl-, wherein the C 1-6  alkyl, C 2-6  alkenyl, C 2-6  alkynyl, phenyl, C 3-7  cycloalkyl, 5-6 membered heteroaryl, 4-7 membered heterocycloalkyl, phenyl-C 1-6  alkyl-, C 3-7  cycloalkyl-C 1-6  alkyl-, (5-6 membered heteroaryl)-C 1-6  alkyl-, and (4-7 membered heterocycloalkyl)-C 1-6  alkyl- of R a10N2 , R b10N2 , R c10N2  and R d10N2  are each optionally substituted with 1, 2, 3, or 4 independently selected R M  substituents; 
         or, any R c10N2  and R d10N2 , attached to the same N atom, together with the N atom to which they are attached, form a 5-6 membered heteroaryl group or a 4-7 membered heterocycloalkyl group, wherein the 5-6 membered heteroaryl group or 4-7 membered heterocycloalkyl group is optionally substituted with 1, 2, 3, or 4 independently selected R M  substituents; 
         R 11N  is selected from H, C 1-6  alkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 1-6  haloalkyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, (4-10 membered heterocycloalkyl)-C 1-6  alkyl-, —C(O)R b11N , —C(O)NR c11N R d11N , —C(O)OR a11N , —C(═NR e11N )R b11N , C(═NR e11N )NR c11N R d11N , —C(═NCN)NR c11N R d11N , —C(═NOR a11N )NR c11N , —S(O) 2 R b11N , —S(O)(═NR c11N )R d11N , and —S(O) 2 NR c11N R d11N , wherein the C 1-6  alkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl- and (4-10 membered heterocycloalkyl)-C 1-6  alkyl- of R 11N  are each optionally substituted with 1, 2, 3, 4, 5, 6, 7, or 8 independently selected R 11NA  substituents; 
         each R a11N , R b11N , R c11N , and R d11N  is independently selected from H, C 1-6  alkyl, C 1-6  haloalkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, and (4-10 membered heterocycloalkyl)-C 1-6  alkyl-, wherein the C 1-6  alkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, and (4-10 membered heterocycloalkyl)-C 1-6  alkyl- of R a11N , R b11N , R c11N , and R d11N  are each optionally substituted with 1, 2, 3, 4, 5, 6, 7, or 8 independently selected R 11NA  substituents; 
         or, any R c11N  and R d11N , attached to the same N atom, together with the N atom to which they are attached, form a 5-10 membered heteroaryl group or a 4-10 membered heterocycloalkyl group, wherein the 5-10 membered heteroaryl group or 4-10 membered heterocycloalkyl group is optionally substituted with 1, 2, 3, 4, 5, 6, 7, or 8 independently selected R 11NA  substituents; 
         each R e11N  is independently selected from H, OH, CN, C 1-6  alkyl, C 1-6  alkoxy, C 1-6  haloalkyl, C 1-6  haloalkoxy, C 2-6  alkenyl, and C 2-6  alkynyl; 
         each R 11NA  is selected from H, D, halo, C 1-6  alkyl, C 1-6  haloalkyl, C 2-6  alkenyl, C 2-6  alkynyl, phenyl, C 3-7  cycloalkyl, 5-6 membered heteroaryl, 4-7 membered heterocycloalkyl, phenyl-C 1-6  alkyl-, C 3-7  cycloalkyl-C 1-6  alkyl-, (5-6 membered heteroaryl)-C 1-6  alkyl-, (4-7 membered heterocycloalkyl)-C 1-6  alkyl-, CN, NO 2 , —OR a11N2 , —OC(O)R b11N2 , ——C(O)NR c11N2 R d11N2 , —C(O)NR c11N2 (OR a11N2 ), —C(O)OR a11N2 , —OC(O)R b11N2 , —OC(O)NR c11N2 R d11N2 , —NR c11NR R d11N2 , —NR c11N2 NR c11N2 R d11N2 , —NR c11N2 C(O)R b11N2 , —NR c11N2 C(O)OR a11N2 , and —NR c11N2 C(O)NR c11N2 R d11N2 , wherein the C 1-6  alkyl, C 2-6  alkenyl, C 2-6  alkynyl, phenyl, C 3-7  cycloalkyl, 5-6 membered heteroaryl, 4-7 membered heterocycloalkyl, phenyl-C 1-6  alkyl-, C 3-7  cycloalkyl-C 1-6  alkyl-, (5-6 membered heteroaryl)-C 1-6  alkyl-, and (4-7 membered heterocycloalkyl)-C 1-6  alkyl- of R 11NA  are each optionally substituted with 1, 2, 3, or 4 independently selected R M  substituents; 
         each R a11N2 , R b11N2 , R c11N2  and R d11N2  is independently selected from H, C 1-6  alkyl, C 1-6  haloalkyl, C 2-6  alkenyl, C 2-6  alkynyl, phenyl, C 3-7  cycloalkyl, 5-6 membered heteroaryl, 4-7 membered heterocycloalkyl, phenyl-C 1-6  alkyl-, C 3-7  cycloalkyl-C 1-6  alkyl-, (5-6 membered heteroaryl)-C 1-6  alkyl-, and (4-7 membered heterocycloalkyl)-C 1-6  alkyl-, wherein the C 1-6  alkyl, C 2-6  alkenyl, C 2-6  alkynyl, phenyl, C 3-7  cycloalkyl, 5-6 membered heteroaryl, 4-7 membered heterocycloalkyl, phenyl-C 1-6  alkyl-, C 3-7  cycloalkyl-C 1-6  alkyl-, (5-6 membered heteroaryl)-C 1-6  alkyl-, and (4-7 membered heterocycloalkyl)-C 1-6  alkyl- of R a11N2 , R b11N2 , R c11N2  and R d11N2  are each optionally substituted with 1, 2, 3, or 4 independently selected R M  substituents; 
         or, any R c11N2  and R d11N2  attached to the same N atom, together with the N atom to which they are attached, form a 5-6 membered heteroaryl group or a 4-7 membered heterocycloalkyl group, wherein the 5-6 membered heteroaryl group or 4-7 membered heterocycloalkyl group is optionally substituted with 1, 2, 3, or 4 independently selected R M  substituents; 
         each R 11  is independently selected from H, D, halo, C 1-6  alkyl, C 1-6  haloalkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, (4-10 membered heterocycloalkyl)-C 1-6  alkyl-, CN, NO 2 , —OR a111 , —SR a111 , NHOR a111 , —C(O)R b111 , —C(O)NR c111 R d111 , —C(O)NR c111 (OR a111 ), —C(O)OR a111 , —OC(O)NR c111 R d111 , —NR c111 R d111 , —NR c111 R d111 , —NR c111 C(O)R b111 , —NR c111 C(O)OR a111 , and —NR c111 C(O)NR c111 R d111 , wherein the C 1-6  alkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, and (4-10 membered heterocycloalkyl)-C 1-6  alkyl- of R 11  are each optionally substituted with 1, 2, 3, 4, 5, 6, 7, or 8 independently selected R 11A  substituents; 
         or, alternatively, two R 11  groups together form an oxo group; 
         each R a111 , R b111 , R c111 , and R d111  is independently selected from H, C 1-6  alkyl, C 1-6  haloalkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, and (4-10 membered heterocycloalkyl)-C 1-6  alkyl-, wherein the C 1-6  alkyl, C 2-6  alkenyl, C 2-6  alkynyl, C 6-10  aryl, C 3-10  cycloalkyl, 5-10 membered heteroaryl, 4-10 membered heterocycloalkyl, C 6-10  aryl-C 1-6  alkyl-, C 3-10  cycloalkyl-C 1-6  alkyl-, (5-10 membered heteroaryl)-C 1-6  alkyl-, and (4-10 membered heterocycloalkyl)-C 1-6  alkyl- of R a111 , R b111 , R c111 , and R d111  are each optionally substituted with 1, 2, 3, 4, 5, 6, 7, or 8 independently selected R 11A  substituents; 
         or, any R c111  and R d111 , attached to the same N atom, together with the N atom to which they are attached, form a 5-10 membered heteroaryl group or a 4-10 membered heterocycloalkyl group, wherein the 5-10 membered heteroaryl group or 4-10 membered heterocycloalkyl group is optionally substituted with 1, 2, 3, 4, 5, 6, 7, or 8 independently selected R 11A  substituents; and 
         each R 11A  is selected from H, D, halo, C 1-6  alkyl, C 1-6  haloalkyl, C 2-6  alkenyl, C 2-6  alkynyl, phenyl, C 3-7  cycloalkyl, 5-6 membered heteroaryl, 4-7 membered heterocycloalkyl, phenyl-C 1-6  alkyl-, C 3-7  cycloalkyl-C 1-6  alkyl-, (5-6 membered heteroaryl)-C 1-6  alkyl-, (4-7 membered heterocycloalkyl)-C 1-6  alkyl-, CN, NO 2 , —OR a112 , —SR a112 , —NHOR a112 , —C(O)R b112 , —C(O)NR c112 R d112 , —C(O)NR c112 (OR a112 ) —C(O)OR a112 , —OC(O)R b112 , —OC(O)NR c112 R b112 , —NR c112 R d112 , —NR c112 NR c112 , R d112 , —NR c112 C(O)R b112 NR c112 C(O)OR a112 , and —NR c112 C(O)NR c112 R d112 , wherein the C 1-6  alkyl, C 2-6  alkenyl, C 2-6  alkynyl, phenyl, C 3-7  cycloalkyl, 5-6 membered heteroaryl, 4-7 membered heterocycloalkyl, phenyl-C 1-6  alkyl-, C 3-7  cycloalkyl-C 1-6  alkyl-, (5-6 membered heteroaryl)-C1.6 alkyl-, and (4-7 membered heterocycloalkyl)-C 1-6  alkyl- of R 11A  are each optionally substituted with 1, 2, 3, or 4 independently selected R M  substituents; and 
         each R a112 , R b112 , R c112 , and R d112  is independently selected from H, C 1-6  alkyl, C 1-6  haloalkyl, C 2-6  alkenyl, C 2-6  alkynyl, phenyl, C 3-7  cycloalkyl, 5-6 membered heteroaryl, 4-7 membered heterocycloalkyl, phenyl-C 1-6  alkyl-, C 3-7  cycloalkyl-C 1-6  alkyl-, (5-6 membered heteroaryl)-C 1-6  alkyl-, and (4-7 membered heterocycloalkyl)-C 1-6  alkyl-, wherein the C 1-6  alkyl, C 2-6  alkenyl, C 2-6  alkynyl, phenyl, C 3-7  cycloalkyl, 5-6 membered heteroaryl, 4-7 membered heterocycloalkyl, phenyl-C 1-6  alkyl-, C 3-7  cycloalkyl-C 1-6  alkyl-, (5-6 membered heteroaryl)-C 1-6  alkyl-, and (4-7 membered heterocycloalkyl)-C 1-6  alkyl- of R a112 , R b112 , R c112  and R d112  are each optionally substituted with 1, 2, 3, or 4 independently selected R M  substituents; or, any R c112  and R d112 , attached to the same N atom, together with the N atom to which they are attached, form a 5-6 membered heteroaryl group or a 4-7 membered heterocycloalkyl group, wherein the 5-6 membered heteroaryl group or 4-7 membered heterocycloalkyl group is optionally substituted with 1, 2, 3, or 4 independently selected R M  substituents. 
       
     
     
         39 . The method of  claim 38 , wherein the disease or disorder is an autoimmune disease or disorder, cancer, cardiovascular disease, or neurodegenerative disease. 
     
     
         40 . The method of  claim 38 , wherein the disease or disorder is lung cancer, melanoma, pancreatic cancer, breast cancer, prostate cancer, liver cancer, color cancer, endometrial cancer, bladder cancer, skin cancer, cancer of the uterus, renal cancer, gastric cancer, seminoma, teratocarcinoma, astrocytoma, neuroblastoma, glioma, or sarcoma. 
     
     
         41 . The method of  claim 40 , wherein the sarcoma is Askin's tumor, sarcoma botryoides, chondrosarcoma, Ewing's sarcoma, malignant hemangioendothelioma, malignant schwannoma, osteosarcoma, alveolar soft part sarcoma, angiosarcoma, cystosarcoma phyllodes, dermatofibrosarcoma protuberans, desmoid tumor, desmoplastic small round cell tumor, epithelioid sarcoma, extraskeletal chondrosarcoma, extraskeletal osteosarcoma, fibrosarcoma, gastrointestinal stromal tumor (GIST), hemangiopericytoma, hemangiosarcoma, Kaposi's sarcoma, leiomyosarcoma, liposarcoma, lymphangiosarcoma, lymphosarcoma, malignant peripheral nerve sheath tumor (MPNST), neurofibrosarcoma, rhabdomyosarcoma, synovial sarcoma, or undifferentiated pleomorphic sarcoma. 
     
     
         42 . The method of  claim 38 , wherein the disease or disorder is acute myeloid leukemia, acute monocytic leukemia, small lymphocyctic lymphoma, chronic lymphocytic leukemia (CLL), chronic myelogenous leukemia (CML), multiple myeloma, T-cell actute lymphoblasic leukemia (T-ALL), cutaneous T-cell lymphoma, large granular lymphocytic leukemia, mature (peripheral) t-cell neoplasm (PTCL), anaplastic large cell lymphoma (ALCL), or lymphoblastic lymphoma. 
     
     
         43 . The method of  claim 42 , wherein the mature (peripheral) t-cell neoplasm (PTCL) is T-cell prolymphocytic leukemia, T-cell granular lymphocytic leukemia, aggressive NK-cell leukemia, mycosis fungoides/Sezary syndrome, naplastic large cell lymphoma (T-cell type), enteropathy type T-cell lymphoma, adult T-cell leukemia/lymphoma, or angioimmunoblastic T-cell lymphoma. 
     
     
         44 . The method of  claim 42 , wherein the anaplastic large cell lymphoma (ALCL) is systemic ALCL or primary cutaneous ALCL. 
     
     
         45 . The method of  claim 38 , wherein the disease or disorder is Burkitt's lymphoma, acute myeloblastic leukemia, chronic myeloid leukemia, non-Hodgkin's lymphoma, Hodgkin's lymphoma, hairy cell leukemia, Mantle cell lymphoma, small lymphocytic lymphoma, follicular lymphoma, xenoderoma pigmentosum, keratoctanthoma, lymphoplasmacytic lymphoma, extranodal marginal zone lymphoma, Waldenstrom's macroglobulinemia, prolymphocytic leukemia, acute lymphoblastic leukemia, myelofibrosis, mucosa-associated lymphatic tissue (MALT) lymphoma, mediastinal (thymic) large B-cell lymphoma, lymphomatoid granulomatosis, splenic marginal zone lymphoma, primary effusion lymphoma, intravascular large B-cell lymphoma, plasma cell leukemia, extramedullary plasmacytoma, smouldering myeloma, monoclonal gammopathy of undetermined significance (MGUS), or diffuse large B cell lymphoma. 
     
     
         46 . The method of  claim 45 , wherein the non-Hodgkin's lymphoma (NHL) is relapsed NHL, refractory NHL, recucurrent follicular NHL, indolent NHL (iNHL), or aggressive NHL (aNHL). 
     
     
         47 . The method of  claim 45 , wherein the diffuse large B cell lymphoma is activated B-cell like (ABC) diffuse large B cell lymphoma, or germinal center B cell (GCB) diffuse large B cell lymphoma. 
     
     
         48 . The method of  claim 45 , wherein the Burkitt's lymphoma is endemic Burkitt's lymphoma, sporadic Burkitt's lymphoma, or Burkitt's-like lymphoma. 
     
     
         49 . The method of  claim 38 , wherein the disease or disorder is rheumatoid arthritis, multiple sclerosis, systemic lupus erythematous, asthma, allergy, allergic rhinitis, pancreatitis, psoriasis, anaphylaxis, glomerulonephritis, inflammatory bowel disease, thrombosis, meningitis, encephalitis, diabetic retinopathy, benign prostatic hypertrophy, myasthenia gravis, Sjogren's syndrome, osteoarthritis, restenosis, or atherosclerosis. 
     
     
         50 . The method of  claim 38 , wherein the disease or disorder is heart hypertropy, cardiac myocyte dysfunction, acute coronary syndrome, chronic obstructive pulmonary disease (COPD), chronic bronchitis, elevated blood pressure, ischemia, ischemia-reperfusion, vasoconstriction, anemia, bacterial infection, viral infection, graft rejection, kidney disease, anaphylactic shock fibrosis, skeletal muscle atrophy, skeletal muscle hypertrophy, angiogenesis, sepsis, graft-versus-host disease, allogeneic or xenogeneic transplantation, glomerulosclerosis, progressive renal fibrosis, idiopathic thrombocytopenic purpura (ITP), autoimmune hemolytic anemia, vasculitis, systemic lupus erythematosus, lupus nephritis, pemphigus, or membranous nephropathy. 
     
     
         51 . The method of  claim 50 , wherein the idiopathic thrombocytopenic purpura (ITP) is relapsed ITP or refractory ITP. 
     
     
         52 . The method of  claim 50 , wherein the vasculitis is Behcet's disease, Cogan's syndrome, giant cell arteritis, polymyalgia rheumatica (PMR), Takayasu's arteritis, Buerger's disease, central nervous system vasculitis, Kawasaki disease, polyarteritis nodosa, Churg-Strauss syndrome, mixed cryoglobulinemia vasculitis (essential or hepatitis C virus (HCV)-induced), Henoch-Schönlein purpura (HSP), hypersensitivity vasculitis, microscopic polyangiitis, Wegener's granulomatosis, or anti-neutrophil cytoplasm antibody associated (ANCA) systemic vasculitis (AASV). 
     
     
         53 . The method of  claim 38 , wherein the disease or disorder is Alzheimer's disease, central nervous system trauma, or stroke. 
     
     
         54 . A compound selected from:
 (S)-5-(6-(1H-Pyrazol-5-yl)pyridazin-4-yl)-2-(1-cyclopropylethyl)-7-(methylsulfonyl)isoindolin-1-one;   (S)-2-(1-Cyclopropylethyl)-5-(6-(3-methyl-1H-pyrazol-5-yl)pyridazin-4-yl)-7-(methylsulfonyl)isoindolin-1-one;   (S)-2-(1-Cyclopropylethyl)-5-(6-(3-methyl-1H-pyrazol-5-yl)pyridazin-4-yl)isoindolin-1-one;   (S)-2-(1-Cyclopropylethyl)-5-(2-(5-methyl-4H-1,2,4-triazol-3-yl)pyridin-4-yl)-7-(methylsulfonyl)isoindolin-1-one;   (S)-2-(1-Cyclopropylethyl)-5-(2-(5-methyl-4H-1,2,4-triazol-3-yl)pyridin-4-yl)isoindolin-1-one;   (S)-2-(1-Cyclopropylethyl)-5-(2-(3-methyl-1H-pyrazol-5-yl)pyridin-4-yl)-7-(methylsulfonyl)isoindolin-1-one; and   (5)-5-(2-(1H-Pyrazol-5-yl)pyridin-4-yl)-2- (1-cyclopropylethyl)-7-(methylsulfonyl)isoindolin-1-one;   or a pharmaceutically acceptable salt thereof   
     
     
         55 . A pharmaceutical composition comprising a compound of  claim 54 , or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable excipient or carrier. 
     
     
         56 . A method of inhibiting an activity of PI3Kγ kinase, comprising contacting the kinase with a compound of  claim 54 , or a pharmaceutically acceptable salt thereof 
     
     
         57 . The method of  claim 56 , wherein the compound, or pharmaceutically acceptable salt thereof, is a selective inhibitor for PI3Kγ over one or more of PI3Kα, PI3Kβ, and PI3Kδ. 
     
     
         58 . A method of treating a disease or disorder in a patient, wherein the disease or disorder is associated with abnormal expression or activity of PI3Kγ kinase, comprising administering to the patient a therapeutically effective amount of a compound of  claim 54 , or a pharmaceutically acceptable salt thereof.

Join the waitlist — get patent alerts

Track US2022340544A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.